Psyence Biomedical Ltd. (PBM)
4.165
+0.04
(+1.09%)
USD |
NASDAQ |
Oct 23, 16:00
4.09
-0.08
(-1.80%)
After-Hours: 20:00
Psyence Biomedical Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.354M |
| October 22, 2026 | 2.251M |
| October 21, 2026 | 3.168M |
| October 20, 2026 | 2.526M |
| October 19, 2026 | 2.251M |
| October 16, 2026 | 2.480M |
| October 15, 2026 | 2.710M |
| October 14, 2026 | 2.274M |
| October 13, 2026 | 3.237M |
| October 12, 2026 | 3.673M |
| October 09, 2026 | 4.200M |
| October 08, 2026 | 4.544M |
| October 07, 2026 | 3.994M |
| October 06, 2026 | 4.315M |
| October 05, 2026 | 4.453M |
| October 02, 2026 | 4.636M |
| October 01, 2026 | 5.370M |
| September 30, 2026 | 5.324M |
| September 29, 2026 | 5.255M |
| September 28, 2026 | 5.794M |
| September 25, 2026 | 5.554M |
| September 24, 2026 | 6.242M |
| September 23, 2026 | 7.274M |
| September 22, 2026 | 6.792M |
| September 21, 2026 | 7.755M |
| Date | Value |
|---|---|
| September 18, 2026 | 7.996M |
| September 17, 2026 | 7.296M |
| September 16, 2026 | 6.150M |
| September 15, 2026 | 6.723M |
| September 14, 2026 | 6.563M |
| September 11, 2026 | 5.187M |
| September 10, 2026 | 4.200M |
| September 09, 2026 | 3.902M |
| September 08, 2026 | 3.673M |
| September 04, 2026 | 3.214M |
| September 03, 2026 | 2.962M |
| September 02, 2026 | 2.824M |
| September 01, 2026 | 2.824M |
| August 31, 2026 | 2.756M |
| August 28, 2026 | 2.458M |
| August 27, 2026 | 2.687M |
| August 26, 2026 | 2.710M |
| August 25, 2026 | 2.595M |
| August 24, 2026 | 2.480M |
| August 21, 2026 | 2.733M |
| August 20, 2026 | 1.816M |
| August 19, 2026 | 2.205M |
| August 18, 2026 | 3.054M |
| August 17, 2026 | 1.082M |
| August 14, 2026 | 0.7835M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Xenon Pharmaceuticals, Inc. | 2.495B |
| Aurinia Pharmaceuticals, Inc. | 1.862B |
| enGene Therapeutics, Inc. | -128.59M |
| Medicus Pharma Ltd. | 155.00M |
| ACADIA Pharmaceuticals, Inc. | 2.514B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.7533M |
| Total Expenses (Quarterly) | 0.7533M |
| EPS Diluted (Quarterly) | -3.178 |